Clinical trials: PTCL Patients Who Achieved Complete Response From Frontline Treatment
PTCL Patients Who Achieved Complete Response From Frontline Treatment
An Open, Single Center, Non-randomized, Single Arm Clinical Study of Evaluating the Efficacy of Selinexor in the Maintenance Treatment of PTCL
To evaluate the efficacy and safety of Selinexor maintenance therapy in PTCL patients who achieved complete response from frontline treatment, and to analyze the relationship between gene mutation in PTCL and disease prognosis…
- Trial name
- NCT05822050
- Testing
- Selinexor
- Where
- China
- Volunteers
- 20 people
- Sponsor
- The First Hospital of Jilin University